WB-308 is a inhibitor of the epidermal growth factor receptor (EGFR). It acts by decreasing NSCLC cell proliferation and colony formation and causing G2/M arrest and apoptosis. References: Li J, Deng H, Hu M, Fang Y, Vaughn A, Cai X, Xu L, Wan W, Li Z, Chen S, Yang X, Wu S, Xiao J. Inhibition of non-small cell lung cancer (NSCLC) growth by a novel small molecular inhibitor of EGFR. Oncotarget. 2015 Mar 30;6(9):6749-61. PubMed PMID: 25730907; PubMed Central PMCID: PMC4466647.

纯度：≥98%

CAS：1373764-87-4